Jump to content

PubMed RSS Feed - - A New Treatment Regimen for Rosacea: OnabotulinumtoxinA.


Recommended Posts

Related Articles

A New Treatment Regimen for Rosacea: OnabotulinumtoxinA.

J Drugs Dermatol. 2012 Dec 1;11(12):e76-9

Authors: Dayan SH, Pritzker RN, Arkins JP

Rosacea is a cutaneous condition with several clinical subtypes that are commonly seen in daily medical practice. There are many different treatment modalities for each of the physical !ndings associated with this disease, and all have varying results. As the use of onabotulinumtoxinA rises, its bene!t in the treatment of a growing number of medical diseases increases. The authors report anecdotal evidence of patients with rosacea experiencing improved symptoms of erythema and "ushing after treatment with intradermal, microdroplets of onabotulinumtoxinA. There were no adverse events reported for any of the treatments. The mechanism of action through a likely neurogenic component to vascular dysfunction, in"ammation, and hypersebaceous activity is reviewed. J Drugs Dermatol. 2012;11(12):e76-e79.

PMID: 23377526 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/PubMed/23377526?dopt=Abstract = URL to article

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

Terms & Rules